|
1) Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007; 298: 299-308
|
|
|
|
2) Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007; 298: 309-16
|
|
|
|
|
|
3) McBride PE. Triglycerides and risk for coronary heart disease. JAMA. 2007; 298: 336-8
|
|
|
|
|
|
4) Ridker PM. Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test？ Clin Chem. 2008; 54: 11-3
|
|
|
|
|
|
5) Yancy WS Jr, Volek JS, Westman EC. Nonfasting triglycerides and cardiovascular risk. JAMA. 2007; 298: 2004
|
|
|
|
|
|
6) Shimano H, Arai H, Harada-Shiba M, et al. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. J Atheroscler Thromb. 2008; 15: 116-21
|
|
|
|
|
7) Priore Oliva C, Pisciotta L, Li Volti G, et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2005; 25: 411-7
|
|
|
|
|
|
8) Marcais C, Verges B, Charriere S, et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest. 2005; 115: 2862-9
|
|
|
|
|
|
9) Kahri J, Fruchart-Najib J, Matikainen N, et al. The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity. Diabetes Care. 2007; 30: 2083-5
|
|
|
|
|
|
10) Jakel H, Nowak M, Helleboid-Chapman A, et al. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins？ Ann Med. 2006; 38: 2-10
|
|
|
|
|
|
11) Duez H, Lamarche B, Uffelman KD, et al. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006; 26: 1357-63
|
|
|
|
|
|
12) Kinoshita M, Kojima M, Matsushima T, et al. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta. 2005; 351: 115-20
|
|
|
|
|
|
13) Sakai N, Uchida Y, Ohashi K, et al. Measurement of fasting serum apoB-48 levels in normo-lipidemic and hyperlipidemic subjects by ELISA. J Lipid Res. 2003; 44: 1256-62
|
|
|
|
|
|
14) Giannattasio C, Zoppo A, Gentile G, et al. Acute effect of high-fat meal on endothelial function in moderately dyslipidemic subjects. Arterioscler Thromb Vasc Biol. 2005; 25: 406-10
|
|
|
|
|
|
15) Ferreira AC, Peter AA, Mendez AJ, et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell micro-particles. Circulation. 2004; 110: 3599-603
|
|
|
|
|
|
16) Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation. 2005; 111: 2518-24
|
|
|
|
|
|
17) Ai M, Tanaka A, Ogita K, et al. Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes. Diabetes Care. 2006; 29: 1180
|
|
|
|
|
|
18) Pedrini MT, Niederwanger A, Kranebitter M, et al. Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels. Diabetologia. 2006; 49: 1612-8
|
|
|
|
|